Both in Surgical Instruments
Haemonetics vs Pulse Biosciences, Inc Common Stock (DE)
Over the past year HAE returned +152.5% and PLSE returned +241.0%; their daily moves had a correlation of -0.02.
HAE +152.5% PLSE +241.0%Growth of $1, one year, split-adjusted
| Metric | HAE | PLSE |
|---|---|---|
| Price | $126.95 | $57.25 |
| Market cap | $5.78B | $4.08B |
| Today | +5.55% | +9.67% |
| 1 month | +22.6% | +15.1% |
| 6 months | +141.0% | +198.0% |
| Year to date | +58.4% | +317.0% |
| 1 year | +152.5% | +241.0% |
| Revenue growth (YoY) | +5.6% | — |
| Gross margin | 59.8% | 37.1% |
| Net margin | 9.7% | −5681.3% |
| P/E (TTM) | 60.0× | — |
| Price / sales | 4.3× | 3,445.8× |
| Net cash | -$950.8M | $101.6M |
| Dividend yield | — | — |
| Volatility (60d) | 49.5% | 62.6% |
| Short % of float | 7.7% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).